Pharmacogenetics: An Important Part of Drug Development with A Focus on Its Application
Open Access
- 29 June 2018
- journal article
- Published by Edwiser International in International Journal of Biomedical Investigation
- Vol. 1 (2), 1-16
- https://doi.org/10.31531/2581-4745.1000111
Abstract
Since the human genome project in 2003, the view of personalized medicine to improve diagnosis and cure diseases at the molecular level became more real. Sequencing the human genome brought some benefits in medicine such as early detection of diseases with a genetic predisposition, treating patients with rare diseases, the design of gene therapy and the understanding of pharmacogenetics in the metabolism of drugs. This review explains the concepts of pharmacogenetics, polymorphisms, mutations, variations, and alleles, and how this information has helped us better understand the metabolism of drugs. Multiple resources are presented to promote reducing the gap between scientists, physicians, and patients in understanding the use and benefits of pharmacogenetics. Some of the most common clinical examples of genetic variants and how pharmacogenetics was used to determine treatment options for patients having these variants were discussed. Finally, we evaluated some of the challenges of implementing pharmacogenetics in a clinical setting and proposed actions to be taken to make pharmacogenetics a standard diagnostic tool in personalized medicine.Keywords
This publication has 105 references indexed in Scilit:
- Personalizing medicine with clinical pharmacogeneticsGenetics in Medicine, 2011
- Variability in response to clopidogrel: how important are pharmacogenetics and drug interactions?British Journal of Clinical Pharmacology, 2011
- CPIC: Clinical Pharmacogenetics Implementation Consortium of the Pharmacogenomics Research NetworkClinical Pharmacology & Therapeutics, 2011
- Implications of the polymorphism of HLA-G on its function, regulation, evolution and disease associationCellular and Molecular Life Sciences, 2010
- VKORC1 Pharmacogenomics SummaryPharmacogenetics and Genomics, 2010
- Clopidogrel pathwayPharmacogenetics and Genomics, 2010
- Impact of OATP transporters on pharmacokineticsBritish Journal of Pharmacology, 2009
- Addressing the Challenges of the Clinical Application of Pharmacogenetic TestingClinical Pharmacology & Therapeutics, 2009
- HLA-B*5701 Screening for Hypersensitivity to AbacavirThe New England Journal of Medicine, 2008
- Structural variation in the human genomeNature Reviews Genetics, 2006